In addition, CUL4B has been reported to be overexpressed in a range of cancers and promotes carcinogenesis through regulating multiple cellular malignant behaviors37–42, suggesting that CUL4B can serve as a potential therapeutic target simultaneously for cancers and intestinal injury caused by radiotherapy of cancers. This evidence concerns the gene CUL4B and cancer.